Navigation Links
Diana Hatsis of Chiltern Will Present at the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) 35th Annual Continuing Education Program Held in Conjunction With the American Academy of Ophthalmology (AAO) Annual Meeting
Date:11/1/2007

LONDON, Nov. 1 /PRNewswire/ -- Chiltern, a leading global clinical research organization, is pleased to announce that Diana Hatsis, R.N., B.S.N., C.O.T. will lecture at the JCAHPO annual continuing education program. Diana who designed an ophthalmic surgical instrument, the Hatsis LASIK Irrigation Cannula, worked in ophthalmic practice for several years prior to joining Chiltern as a Clinical Research Associate (CRA). The meeting will take place in New Orleans, Louisiana from November 9 - 13, 2007. The JCAHPO meetings will be located at the Hilton Riverside. Diana will be the lead instructor on three lectures, and co-instructing one of them with her brother, Dr. Alexander Hatsis, M.D., F.A.C.S. Dr. Hatsis was the first surgeon to perform refractive surgery with the Excimer laser on Long Island in 1995.

Monday, Nov. 12 from 11:30 am to 12:25 pm - Session 07M04

Wearing Many Hats: Managing Clinical Trials in an Ophthalmic Private

Practice

Tuesday, Nov, 13 from 10:20 am to 11:15 am - Session 04TU3

LASIK Complications (Lead Instructor: A. Hatsis, MD)

Tuesday, Nov, 13 from 11:30 am to 12:25 pm - Session 04TU4

Sands of the Sahara: A Refractive Emergency (co-instructor A. Hatsis, MD)

Tuesday, Nov, 13 from 1:50 pm to 2:45 pm - Session 07M06

Basic Surgical Assisting

"This will be my eighth year presenting at JCAHPO during AAO's annual meeting, it is always a great honor to be invited and a pleasure to teach and provide continuing education for health professionals in the field of ophthalmology," said Diana Hatsis. "My background in ophthalmology, eye surgeries, working in a private practice and now clinical research allows me to deliver courses with an insight in various aspects of the profession," Diana added.

"One of Chiltern's therapeutic expertise is ophthalmology and we have completed numerous trials, in various indications, in this area. Diana's expertise in the field of ophthalmology is well established and her passion about sharing her knowledge with others is reflected in the number of speaking engagements she has given over the years," said Kathy Zimmermann, Chiltern's Executive Director, Clinical Monitoring, Americas.

About Chiltern:

Established in 1982, Chiltern is a leading global contract research organization with extensive experience of running and staffing international Phase I to Phase IV clinical trials across a broad therapeutic range for a wide variety of clients. Chiltern employs more than 1100 people with 20 offices across the United States, United Kingdom, Germany, France, Italy, Spain, Poland, Czech Republic, Ukraine, India and South Africa. Chiltern provides services including Phase I and laboratory support, Global Clinical Development, Staff Resourcing, Biometrics, Regulatory and Medical Affairs.

For more information contact:

Catherine Lemercier

Chiltern International, Inc.

2111 Palomar Airport Road

Suite 200

Carlsbad

CA 92011

Tel: 1 (760) 707 5025

Fax: 1 (760) 707 5022

Email: Catherine.Lemercier@chiltern.com

Chiltern: Understanding


'/>"/>
SOURCE Chiltern International, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Bill to Ban Abortion In Indiana Introduced
2. Prince Harry Launches AIDS Charity In Memory Of Princess Diana
3. Over 300 Ill After Eating at Olive Garden, Indianapolis
4. Many Indiana Citizens Do Not Possess Health Insurance Coverage
5. Diana Could Have Been Saved Had She Been Rushed to Hospital
6. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
7. Researchers Present Ways To Reduce The Risk Of Dementia
8. Researchers Present Data Regarding The Efficiency Of Herbs
9. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
10. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
11. Drug Reactions First Present Themselves In The Mouth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... Los Angeles, California (PRWEB) , ... January 23, 2017 , ... ... “Golden Era” principles, has added Mr. Olympia Classic Physique bodybuilder Breon Ansley to its ... back began competing as a bodybuilder in 2012 and in less than a year ...
(Date:1/23/2017)... ... ... a story of love and redemption, hope and uncertainty as a girl makes her ... Inn at the Mill” is the creation of published author, Lois Kulp, who was born ... Berks County on Crow Hill. The inn, the mill and "Post Yokel" are ...
(Date:1/23/2017)... ... January 23, 2017 , ... “Life Under Blankets”: an ... an early age. “Life Under Blankets” is the creation of published author, Kimberly Mitchell, ... Campus in Chicago. She went on to pursue a master’s degree in education in ...
(Date:1/22/2017)... ... January 22, 2017 , ... Phytocéane invites clients to take an exotic ... the world with ZANZIBAR MILKY CREAM. Inspired by the beauty of Zanzibar, a Tanzanian ... Oil and moisturizing vegetal coral to create this gentle, velvety body cream to envelop ...
(Date:1/22/2017)... ... January 22, 2017 , ... Medical lab testing through hospitals and ... a simple test will take days to arrive to the end customer, having to ... access to their lab tests, bypassing the cost and delay of traditional means. Now ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... , January 23, 2017 Longer life expectancy and ... the global market for medical device technologies. BCC Research reveals ... Asia-Pacific region, should see strong growth due to ... disposable incomes. Continue Reading ... ...
(Date:1/23/2017)... 2017 NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical collaboration agreement with the Children,s Hospital of ... M.D., a US key opinion leader in the mitochondrial medicine ... ... from NeuroVive,s research program, NVP015, in certain experimental disease models. ...
(Date:1/21/2017)... 20, 2017 ResMed (NYSE: RMD ), BMC ... Winter Haven, Florida ) today announced they have agreed on ... 3B will be permitted to sell their existing products in exchange ... settlement payment to 3B to close the Florida ... an admission of liability or wrongdoing by any party. ...
Breaking Medicine Technology: